Mrgfus strtctc ablt trgt icr
Choose 61735 for stereotactic radiofrequency lesioning. Choose 61715 when the intracranial target is ablated using MR-guided focused ultrasound.
CMS RVU26D · Effective 2026-10-01
Reports unilateral stereotactic radiofrequency lesioning of intracranial neural tissue to treat a movement disorder, such as tremor or Parkinson disease. Compare 61735 office and facility rates across CMS payment localities in Alaska.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
Alaska has 1 payment locality in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the payment area shown below, using the same CMS release.
No supported rate
$1832.13
1 of 1 localities have a supported rate.
Payment area: Alaska*
One mapped payment locality.
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Functional neurosurgery
Reports unilateral stereotactic radiofrequency lesioning of intracranial neural tissue to treat a movement disorder, such as tremor or Parkinson disease.
This service is stereotactic radiofrequency lesioning of a deep intracranial target to manage a movement disorder. A functional neurosurgeon typically performs it in an operating room, using stereotactic equipment to guide treatment. Clinical contexts may include selected patients with tremor, Parkinson disease, or dystonia when an ablative approach is chosen. The code represents a unilateral procedure; document the treated side and target, the movement disorder being addressed, and the operative technique.
Report this code when the surgeon performs the described intracranial lesioning, rather than implanting stimulation electrodes or using focused ultrasound. It has a 90-day global period, including the day-before preoperative visit and 90 days of related postoperative care. When multiple procedures are performed in the same session, the highest-valued procedure is paid in full and other procedures are subject to the standard 50% reduction. Modifier 50 is inappropriate. Assistant-at-surgery payment is barred; co-surgeon payment requires supporting documentation, and team surgery is not permitted.
16
Medicare services in 2024 · #6046 by national volume
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Office rates for Alaska, from the same CMS release.
Mrgfus strtctc ablt trgt icr
Choose 61735 for stereotactic radiofrequency lesioning. Choose 61715 when the intracranial target is ablated using MR-guided focused ultrasound.
61735 creates a lesion in neural tissue; 61863 is for implanting a neurostimulator electrode array.
61735 is an ablative procedure. 61867 describes electrode-array implantation with intraoperative recording, not lesioning.
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
1 of 1 payment localities
Office / nonfacility
Unavailable
Facility
$1832.13
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
Each RVU component is multiplied by its own geographic practice cost index (GPCI). The three adjusted components are added, then multiplied by the conversion factor. These are the inputs used for 61735 in Alaska*.
PPRRVU2026_Oct_nonQPP.csv
6,877
GPCI2026.csv
5
| Component | RVU | Locality factor | Adjusted |
|---|---|---|---|
| Physician work | 21.79 | × 1.500 | 32.6850 |
| Practice expense | 16.06 | × 1.065 | 17.1039 |
| Malpractice | 9.19 | × 0.551 | 5.0637 |
| Total RVUs | 54.8526 | ||
| Conversion factor | × 33.4009 | ||
Facility rate, Alaska*$1832.13
| Component | RVU | Local GPCI |
|---|---|---|
| Work | 21.79 | 1.5 |
| Practice expense | 16.06 | 1.065 |
| Malpractice | 9.19 | 0.551 |
(21.79 × 1.5 + 16.06 × 1.065 + 9.19 × 0.551) × $33.4009 = $1832.13
The office and facility calculations use their respective practice-expense RVUs. The facility amount here is the physician fee, not a separate hospital or facility bill.
This code is for stereotactic intracranial radiofrequency lesioning. Use 61715 for the distinct MR-guided focused ultrasound ablation approach.
No. This code describes lesioning neural tissue; 61863 and 61867 describe implantation of neurostimulator electrodes.
No. CMS identifies bilateral adjustment as inappropriate for this code, so modifier 50 is not appropriate.
Document the movement disorder, intracranial target, treated side, stereotactic approach, and radiofrequency lesioning performed.
The 90-day global period includes the day-before preoperative visit and 90 days of related postoperative care.
Assistant-at-surgery payment is barred. Co-surgeon payment is available only with supporting documentation; team surgery is not permitted.
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.